levofloxacin has been researched along with Chlamydia Infections in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Fukuda, S; Irie, M; Kunimoto, H; Morihara, D; Sakisaka, S; Shakado, S; Takata, K; Takeyama, Y; Tanaka, T; Umeda, K; Yamauchi, R; Yokoyama, K | 1 |
| Hosobe, T; Kato, T; Onodera, S; Onoe, Y; Yoshida, M | 1 |
| Araki, I; Baba, M; Kageyama, S; Nakano, E; Okada, Y; Yamashita, H | 1 |
| Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
| Deguchi, T; Hatazaki, K; Ito, S; Kondo, H; Mizutani, K; Nakane, K; Nakano, M; Ohinishi, M; Shimuta, K; Tsuchiya, T; Yasuda, M; Yokoi, S | 1 |
| Judlin, P; Thiebaugeorges, O | 1 |
| Garlaschi, MC; Magri, V; Markotić, A; Marras, E; Perletti, G; Restelli, A; Skerk, V | 1 |
| Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T | 1 |
| Ando, Y; Fujiwara, M; Hoshina, S; Izumi, K; Kinoshita, C; Kurashima, M; Mikamo, H; Nakabe, K; Takahashi, K; Yamagishi, Y; Yoshimura, M; Yoshioka, M | 1 |
| Clark, G; Perroud, N; Reusser, P | 1 |
| Hammerschlag, MR; Kutlin, A; Reznik, T; Roblin, PM | 1 |
| Baltch, AL; Bopp, LH; Carlyn, CJ; Carpenter-Knaggs, A; Hibbs, JR; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Hammerschlag, MR; Hawser, S; Islam, K; Kohlhoff, SA; Reznik, T; Roblin, PM | 1 |
| Dunbar, LM; Kahn, JB; Khashab, MM; Tennenberg, AM; Xiang, JX; Zadeikis, N | 1 |
| Baltch, AL; Bopp, LH; Carpenter, AN; Halse, TA; Ritz, WJ; Smith, RP | 1 |
| Fujimoto, Y; Komeda, H; Takada, T; Uno, M; Yamada, Y | 1 |
| Deguchi, T; Fukushi, H; Ishihara, S; Ito, S; Kubota, Y; Maeda, S; Takahashi, Y; Tamaki, M; Yasuda, M; Yokoi, S | 1 |
| Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K | 1 |
| Furusyo, N; Hayashi, J; Kikuchi, K; Maeda, S; Ohnishi, H; Sawayama, Y; Tatsukawa, M | 1 |
| Chimura, T | 2 |
| Cevenini, R; Donati, M; Marchetti, F; Rumpianesi, F; Sambri, V | 1 |
| Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y | 1 |
| Hammerschlag, MR; Roblin, PM | 1 |
2 review(s) available for levofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Duodenal Ulcer; Hepatitis; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pelvic Inflammatory Disease; Peritonitis; Urine | 2018 |
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
5 trial(s) available for levofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease; Sexually Transmitted Diseases; Vaginosis, Bacterial | 2009 |
[Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis].
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Administration Schedule; Endometritis; Female; Glycosuria; Guanosine Triphosphate; Humans; Levofloxacin; Ofloxacin; Product Surveillance, Postmarketing; Treatment Outcome; Uterine Cervicitis; Young Adult | 2011 |
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 2004 |
Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection.
Topics: Aged; Anti-Bacterial Agents; Anticholesteremic Agents; Carotid Arteries; Carotid Artery Diseases; Chlamydia Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Probucol; Ultrasonography | 2007 |
[Effects of levofloxacin once-a-day therapy on uterine cervicitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Drug Administration Schedule; Female; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Middle Aged; Mucus; Ofloxacin; Uterine Cervicitis | 1999 |
17 other study(ies) available for levofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
[Efficacy and safety of levofloxacin to non-gonorrheal urethritis].
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Humans; Levofloxacin; Male; Middle Aged; Mycoplasma genitalium; Mycoplasma Infections; Ofloxacin; Urethritis | 2012 |
[Questionnaire survey on medical care for male urethritis in community clinics in Shiga prefecture].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Drug Administration Schedule; Drug Utilization; Female; Gonorrhea; Health Knowledge, Attitudes, Practice; Humans; Japan; Levofloxacin; Male; Nucleic Acid Amplification Techniques; Patient Care; Practice Guidelines as Topic; Sexual Partners; Sexually Transmitted Diseases, Bacterial; Specialization; Surveys and Questionnaires; Urethritis | 2014 |
Haemophilus influenzae Isolated From Men With Acute Urethritis: Its Pathogenic Roles, Responses to Antimicrobial Chemotherapies, and Antimicrobial Susceptibilities.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Haemophilus influenzae; Humans; Leukocyte Count; Levofloxacin; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Retrospective Studies; Urethritis | 2017 |
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis; Semen; Urethra | 2010 |
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Mycoplasma genitalium; Mycoplasma Infections; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis; Young Adult | 2011 |
[Multisystemic severe infection with Chlamydia pneumoniae].
Topics: Adult; Anti-Infective Agents; Capillary Leak Syndrome; Chlamydia Infections; Chlamydophila pneumoniae; Humans; Levofloxacin; Male; Ofloxacin; Skin; Treatment Outcome; Vasculitis | 2002 |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifamycins | 2003 |
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.
Topics: Anti-Infective Agents; Carcinoma; Chlamydia Infections; Chlamydophila pneumoniae; Hepatocytes; Humans; Interleukin-6; Levofloxacin; Liver Neoplasms; Ofloxacin; Tumor Cells, Cultured | 2003 |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Folic Acid Antagonists; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pyrimidines | 2004 |
In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Databases, Genetic; DNA, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 16S | 2004 |
[Clinical study of male urethritis in Oogaki Municipal Hospital].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Fluoroquinolones; Gonorrhea; Hospitals, Municipal; Humans; Japan; Levofloxacin; Male; Middle Aged; Minocycline; Naphthyridines; Ofloxacin; Sexual Partners; Sexually Transmitted Diseases, Bacterial; Spectinomycin; Urethritis | 2005 |
Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Ofloxacin; Urethritis | 2004 |
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Female; Humans; Japan; Levofloxacin; Ofloxacin; Pharyngitis; Prevalence; Sex Work; Sexual Behavior; Uterine Diseases | 2006 |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
Topics: Actihaemyl; Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Chloramphenicol; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Immunoglobulin G; Levofloxacin; Middle Aged; Ofloxacin; Pessaries; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervicitis | 1997 |
Comparative in-vitro activity of levofloxacin against Chlamydia spp.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Tetracyclines | 1998 |
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Outcome Assessment, Health Care; Pneumonia, Bacterial | 2000 |
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field].
Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Levofloxacin; Maternal-Fetal Exchange; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious | 2002 |